Clinical Benefits & Effects
Additionally, analogues containing the quinolinium scaffold lacked inhibitory activity against enzymes in the NAD + salvage pathway that bind nicotinamide-containing substrate, including NAMPT[27, 32] and the NAD + -dependent SIRT1 enzyme, which deacetylates NAD + to produce NA, a product inhibitor of SIRT1.[33] These results suggest that quinolinium-based NNMT inhibitors achieve selectivity by specifically interacting with the NA-binding pocket of NNMT,[17] unlike several known non-selective methyltransferase inhibitors that interact with the SAM-binding pocket, which is highly conserved among SAM-dependent methyltransferases.[34, 35] Membrane-permeable NNMT inhibitors reduced intracellular 1-MNA levels in a concentration-dependent manner and at pharmacologically relevant concentrations that did not impact cell viability, suggesting these small molecules interact directly with NNMT in cells
Dosierung Soweit nicht anders verordnet wird zu Beginn der Behandlung in den ersten Wochen nach Diagnosestellung 1 ml "Vitamin B12 Depot Hevert" (entsprechend 500 g Hydroxocobalaminacetat) 2mal pro Woche verabreicht
[6] [7] Glutathione Injection should not be used in individuals with a known hypersensitivity or allergy to glutathione or any component of the formulation
Return to all activities immediately
